Rheumatoid arthritis in women: Still associated with an increased mortality

Annals of the Rheumatic Diseases

Volumn 61, Issue 11, 2002, Pages 955-956

  Goodson, N ^a   Symmons, Deborah ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION; INFLAMMATORY DISEASE; MORTALITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; SMOKING;

EID: 0036838540     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.11.955     Document Type: Short Survey

References (28)

1. Wolfe F, Mitchell DM, Sibley JT, Fries JF. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
2. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193-202.
3. Kvalvik AG. Mortality in rheumatoid arthritis. Rheumatology in Europe 1996;25:9-14.
4. Symmons DPM, Jones MA, Scott DL, Prior P. Longterm mortality outcomes in patients with rheumatoid arthritis: Early presenters continue to do well. J Rheumatol 1998;25:1072-7.
5. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58:11-14.
6. Kroot EJA, van Leeuwen MA, van Rijswijk MH, Prevoo MLL, van 't Hof MA, vna de Putte LBA, et al. No increased mortality in patients with rheumatoid arthritis: Up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-8.
7. Mikuls TR, Saag KG, Criswell LA, Merlino L, Kaslow RA, Shelton BJ, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: Results from the Iowa Women's Health Study. Ann Rheum Dis 2002;61:994-9.
8. Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002;46:625-31.
9. Goodson NJ, Wiles NJ, Lunt M, Barrett E, Silman AJ, Symmons DPM. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (in press).
10. Glennas A, Kvien TK, Andrup O, Karstensen B, Munthe E. Recent onset arthritis in the elderly: A 5 year longitudinal observational study. J Rheumatol 2000;27:101-8.
11. van Schaardenburg D, Hazes J, de Boer A, Zwinderman AH, Meijers KAE, Breedveld FC. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45-52.
12. Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
13. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JMW. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum 1996;39:266-71.
14. Doll R. Uncovering the effects of smoking: Historical perspective. Stat Methods Med Res 1998;7:87-117.
15. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27:630-7.
16. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H. Smoking, rheumatoid factor iso types and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000;39:1202-5.
17. Symmons DPM, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG. Blood transfusion, smoking and obesity as risk factors for development of rheumatoid arthritis: Results from a primary care based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61.
18. Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001;60:223-7.
19. Wållberg-Jonsson S, Öhman ML, Rantapää-Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
20. Koenig W. Inflammation and coronary heart disease: An overview. Cardiol Rev 2001;9:31-5.
21. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: The women's health and aging study. Circulation 2001;103:947-53.
22. Chehata JC, Hassell AB, Clarke SA, Mattey DL, Jones MA, Jones PW, et al. Mortality in rheumatoid arthritis: Relationship to single and composite measures of disease activity. Rheumatology (Oxford) 2001;40:447-52.
23. Wållberg-Jonsson S, Johansson H, Rantapää-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
24. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002;359:1173-7.
25. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom - New estimates for a new century. Rheumatology (Oxford) 2002 (in press).
26. Silman AJ. The changing face of rheumatoid arthritis: Why the decline in incidence? Arthritis Rheum 2002;46:579-81.
27. Spector TD, Roman E, Silman AJ. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990;33:782-9.
28. Bergstrom U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999;28:160-5.